Insulet Return on Investment 2007-2019 | PODD
Current and historical return on investment (ROI) values for Insulet (PODD) over the last 10 years.
| Insulet ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2019-03-31 | $0.03B | $0.82B | 4.30% |
| 2018-12-31 | $0.03B | $0.80B | 3.50% |
| 2018-09-30 | $0.01B | $0.78B | 1.33% |
| 2018-06-30 | $0.01B | $0.76B | 0.76% |
| 2018-03-31 | $-0.00B | $0.74B | -0.35% |
| 2017-12-31 | $-0.01B | $0.73B | -1.44% |
| 2017-09-30 | $-0.01B | $0.42B | -2.47% |
| 2017-06-30 | $-0.01B | $0.41B | -2.51% |
| 2017-03-31 | $-0.01B | $0.40B | -2.30% |
| 2016-12-31 | $-0.01B | $0.40B | -3.69% |
| 2016-09-30 | $-0.02B | $0.39B | -7.98% |
| 2016-06-30 | $-0.04B | $0.20B | -17.64% |
| 2016-03-31 | $-0.05B | $0.20B | -22.70% |
| 2015-12-31 | $-0.05B | $0.21B | -20.94% |
| 2015-09-30 | $-0.04B | $0.23B | -14.29% |
| 2015-06-30 | $-0.02B | $0.25B | -9.19% |
| 2015-03-31 | $-0.01B | $0.26B | -5.55% |
| 2014-12-31 | $-0.01B | $0.25B | -3.61% |
| 2014-09-30 | $-0.01B | $0.25B | -4.04% |
| 2014-06-30 | $-0.02B | $0.25B | -9.81% |
| 2014-03-31 | $-0.03B | $0.24B | -10.25% |
| 2013-12-31 | $-0.03B | $0.24B | -11.97% |
| 2013-09-30 | $-0.04B | $0.24B | -16.04% |
| 2013-06-30 | $-0.03B | $0.25B | -13.23% |
| 2013-03-31 | $-0.03B | $0.24B | -17.87% |
| 2012-12-31 | $-0.04B | $0.15B | -22.54% |
| 2012-09-30 | $-0.04B | $0.15B | -24.05% |
| 2012-06-30 | $-0.04B | $0.16B | -23.89% |
| 2012-03-31 | $-0.05B | $0.18B | -24.74% |
| 2011-12-31 | $-0.04B | $0.19B | -24.23% |
| 2011-09-30 | $-0.04B | $0.19B | -25.65% |
| 2011-06-30 | $-0.04B | $0.20B | -26.98% |
| 2011-03-31 | $-0.04B | $0.13B | -26.37% |
| 2010-12-31 | $-0.04B | $0.14B | -28.94% |
| 2010-09-30 | $-0.04B | $0.13B | -29.60% |
| 2010-06-30 | $-0.05B | $0.14B | -35.25% |
| 2010-03-31 | $-0.05B | $0.14B | -44.64% |
| 2009-12-31 | $-0.06B | $0.15B | -54.72% |
| 2009-09-30 | $-0.07B | $0.10B | -80.89% |
| 2009-06-30 | $-0.08B | $0.08B | -83.77% |
| 2009-03-31 | $-0.09B | $0.10B | -78.54% |
| 2008-12-31 | $-0.09B | $0.09B | -83.18% |
| 2008-09-30 | $-0.08B | $0.12B | -69.64% |
| 2008-06-30 | $-0.07B | $0.14B | -65.47% |
| 2008-03-31 | $-0.06B | $0.09B | -57.14% |
| 2007-12-31 | $-0.05B | $0.11B | -60.00% |
| 2007-09-30 | $-0.05B | $0.12B | -69.63% |
| 2007-06-30 | $-0.04B | $0.13B | -108.39% |
| 2007-03-31 | $-0.04B | $0.01B | -650.00% |
| 2006-12-31 | $-0.04B | $0.02B | -777.78% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $6.926B | $0.564B |
| INSULET CORPORATION is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use components with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-dependent diabetes. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $148.615B | 28.85 |
| Medtronic (MDT) | Ireland | $132.640B | 18.95 |
| Stryker (SYK) | United States | $76.039B | 27.14 |
| Boston Scientific (BSX) | United States | $58.018B | 27.81 |
| Baxter (BAX) | United States | $41.696B | 26.28 |
| Zimmer Biomet Holdings (ZBH) | United States | $23.900B | 15.35 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $18.990B | 0.00 |
| ResMed (RMD) | United States | $17.191B | 32.85 |
| Canopy Growth (CGC) | Canada | $13.701B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.984B | 47.63 |
| Aurora Cannabis (ACB) | Canada | $7.565B | 74.60 |
| Hill-Rom Holdings (HRC) | United States | $6.984B | 21.17 |
| Perrigo (PRGO) | Ireland | $6.188B | 10.46 |
| Haemonetics (HAE) | United States | $5.977B | 48.79 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $5.182B | 0.00 |
| ICU Medical (ICUI) | United States | $5.138B | 30.66 |
| Hutchison China MediTech (HCM) | China | $3.897B | 0.00 |
| Neogen (NEOG) | United States | $3.107B | 50.52 |
| NuVasive (NUVA) | United States | $2.983B | 24.36 |
| Agios Pharmaceuticals (AGIO) | United States | $2.912B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.413B | 51.42 |
| Quidel (QDEL) | United States | $2.341B | 24.29 |
| Aphria (APHA) | $1.735B | 0.00 | |
| Cardiovascular Systems (CSII) | United States | $1.450B | 832.80 |
| HEXO (HEXO) | $1.317B | 0.00 | |
| Phibro Animal Health (PAHC) | United States | $1.244B | 18.64 |
| AtriCure (ATRC) | United States | $1.171B | 0.00 |
| VAREX IMAGING (VREX) | United States | $1.134B | 24.08 |
| Lantheus Holdings (LNTH) | United States | $1.078B | 28.62 |
| OrganiGram Holdings (OGI) | Canada | $0.947B | 0.00 |
| NanoString Technologies (NSTG) | United States | $0.920B | 0.00 |
| PetIQ (PETQ) | United States | $0.860B | 20.88 |
| Quanterix (QTRX) | United States | $0.818B | 0.00 |
| MacroGenics (MGNX) | United States | $0.801B | 0.00 |
| Omeros (OMER) | United States | $0.762B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.733B | 20.55 |
| Cerus (CERS) | United States | $0.674B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.601B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.544B | 25.03 |
| LeMaitre Vascular (LMAT) | United States | $0.542B | 26.25 |
| Surmodics (SRDX) | United States | $0.533B | 77.45 |
| Meridian Bioscience (VIVO) | United States | $0.484B | 14.79 |
| Evolus (EOLS) | United States | $0.390B | 0.00 |
| Vapotherm (VAPO) | United States | $0.368B | 0.00 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.355B | 0.00 |
| Zynex (ZYXI) | United States | $0.339B | 35.00 |
| Utah Medical Products (UTMD) | United States | $0.316B | 21.87 |
| BioLife Solutions (BLFS) | United States | $0.286B | 89.41 |
| Cytosorbents (CTSO) | United States | $0.209B | 0.00 |
| Bovie Medical (APYX) | United States | $0.199B | 0.00 |
| Owens & Minor (OMI) | United States | $0.191B | 4.04 |
| Rockwell Medical (RMTI) | United States | $0.178B | 0.00 |
| Chimerix (CMRX) | United States | $0.172B | 0.00 |
| Fonar (FONR) | United States | $0.145B | 7.63 |
| Female Health (VERU) | United States | $0.132B | 0.00 |
| BRAINSWAY LTD (BWAY) | Israel | $0.112B | 0.00 |
| Neurotrope (NTRP) | United States | $0.107B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.102B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.088B | 0.00 |
| United-Guardian (UG) | United States | $0.086B | 18.98 |
| Surface Oncology (SURF) | United States | $0.081B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.062B | 0.00 |
| ImmuCell (ICCC) | United States | $0.047B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.040B | 13.83 |
| Senestech (SNES) | United States | $0.037B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.030B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.020B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.015B | 0.00 |
| Myomo (MYO) | United States | $0.014B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.011B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.010B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.007B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.006B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.005B | 3.86 |
